Differences between serum and whole blood levels of cytomegalo and Epstein Barr virus DNA.

被引:0
|
作者
Kullberg-Lindh, Carola
Olofsson, Sigvard
Lindh, Manus
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Virol, Gothenburg, Sweden
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
148
引用
收藏
页码:69 / 69
页数:1
相关论文
共 50 条
  • [21] Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA
    Yao, Ji-Jin
    Lin, Li
    Jin, Ya-Nan
    Wang, Si-Yang
    Zhang, Wang-Jian
    Zhang, Fan
    Zhou, Guan-Qun
    Cheng, Zhi-Bin
    Qi, Zhen-Yu
    Sun, Ying
    CANCER SCIENCE, 2017, 108 (08) : 1640 - 1646
  • [22] SPECIFIC IMMUNE SERUM TO THE EPSTEIN-BARR VIRUS-DNA POLYMERASE
    PETIT, RG
    LEUNG, K
    SHAW, JE
    JOURNAL OF VIROLOGY, 1987, 61 (10) : 3331 - 3334
  • [23] Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma
    Lo, YMD
    Chan, WY
    Ng, EKW
    Chan, LYS
    Lai, PBS
    Chung, SCS
    CLINICAL CHEMISTRY, 2001, 47 (02) : 366 - 366
  • [24] Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma
    Lo, YMD
    Chan, WY
    Ng, EKW
    Chan, LYS
    Lai, PBS
    Tam, JS
    Chung, SCS
    CLINICAL CANCER RESEARCH, 2001, 7 (07) : 1856 - 1859
  • [25] Quantification of Whole Blood Epstein-Barr Virus (EBV) DNA as a Biomarker for Non-Hodgkin's Lymphoma
    Hwang, S.
    Lee, E.
    Chang, C. L.
    Shin, H.
    Chung, J.
    Kim, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 577 - 577
  • [26] Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma
    Park, Ji Hyun
    Yoon, Dok Hyun
    Kim, Shin
    Park, Jung Sun
    Park, Chan-sik
    Sung, Heungsup
    Lee, Sang-Wook
    Huh, Jooryung
    Suh, Cheolwon
    ANNALS OF HEMATOLOGY, 2016, 95 (05) : 801 - 808
  • [27] Toward standardization of Epstein-Barr virus DNA load monitoring: Unfractionated whole blood as preferred clinical specimen
    Stevens, SJC
    Pronk, I
    Middeldorp, JM
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) : 1211 - 1216
  • [28] Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma
    Ji Hyun Park
    Dok Hyun Yoon
    Shin Kim
    Jung Sun Park
    Chan-sik Park
    Heungsup Sung
    Sang-Wook Lee
    Jooryung Huh
    Cheolwon Suh
    Annals of Hematology, 2016, 95 : 801 - 808
  • [29] Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
    Kim, Yu Ri
    Kim, Soo-Jeong
    Cheong, June-Won
    Chung, Haerim
    Jang, Ji Eun
    Kim, Yundeok
    Yang, Woo-Ick
    Min, Yoo Hong
    Kim, Jin Seok
    ONCOTARGET, 2017, 8 (54) : 92312 - 92323
  • [30] Performance of the Real-Q EBV Quantification Kit for Epstein-Barr Virus DNA Quantification in Whole Blood
    Huh, Hee Jae
    Park, Jong Eun
    Kim, Ji-Youn
    Yun, Sun Ae
    Lee, Myoung-Keun
    Lee, Nam Yong
    Kim, Jong-Won
    Ki, Chang-Seok
    ANNALS OF LABORATORY MEDICINE, 2017, 37 (02) : 147 - 150